Replies to post #162567 on Cytodyn Inc (CYDY)

[DonDonDonDon]

More people survived in the Leronlimab arm

Only with critical patients. Severe patients likely had a higher mortality in the leronlimab arm. And with the critical patients, if 2 more placebo had lived instead of dying, the leronlimab arm of critical patients would have had a higher mortality rate than placebo.